Sign up for our eNewsletter
[f] [t] [in] [blog]

Portfolio Companies

Bioscience
Clean Technology
Information Technology
Medical Device

Arvinas, Inc.

CEO: Manuel Litchman, M.D.

Year Established: 2012

Description: Arvinas is a pharmaceutical company focused on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, autoimmune and rare diseases. Central to Arvinas’s proprietary approach is the targeting of disease-causing proteins for degradation, thus eliminating them from the body.

Web: http://www.arvinas.com/

CI Representative:
Daniel Wagner
Managing Director, Investments

[photo]